Reducing the risk of perinatal HIV-1 transmission with zidovudine: Results and implications of AIDS Clinical Trials Group protocol 076

被引：0
|
作者：
Mofenson, LM
机构：
来源：
ACTA PAEDIATRICA | 1997年 / 86卷
关键词：
ACTG; 076; perinatal HIV transmission; prevention; zidovudine;
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
This paper reviews the rationale for the AIDS Clinical Trials Group (ACTG) protocol 076 design, the study results and the implications of these results, including discussion of the US Public Health Service Task Force recommendations on the use of zidovudine to reduce perinatal transmission and for prenatal human immunodeficiency virus (HIV) counseling and testing.
引用
收藏
页码：89 / 96
页数：8
相关论文
共 50 条
  • [1] ZIDOVUDINE FOR THE REDUCTION OF PERINATAL HUMAN-IMMUNODEFICIENCY-VIRUS TRANSMISSION - PEDIATRIC AIDS CLINICAL-TRIALS GROUP PROTOCOL-076 - RESULTS AND TREATMENT RECOMMENDATIONS
    CONNOR, EM
    MOFENSON, LM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (06) : 536 - 541
  • [2] Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in Pediatric AIDS Clinical Trials Group protocol 076
    Eastman, PS
    Shapiro, DE
    Coombs, RW
    Frenkel, LM
    McSherry, GD
    Britto, P
    Herman, SA
    Sperling, RS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03): : 557 - 564
  • [3] Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of pediatric AIDS clinical trials group protocol 185
    Stiehm, ER
    Lambert, JS
    Mofenson, LM
    Bethel, J
    Whitehouse, J
    Nugent, R
    Moye, J
    Fowler, MG
    Mathieson, BJ
    Reichelderfer, P
    Nemo, GJ
    Korelitz, J
    Meyer, WA
    Sapan, CV
    Jimenez, E
    Gandia, J
    Scott, G
    O'Sullivan, MJ
    Kovacs, A
    Stek, A
    Shearer, WT
    Hammill, H
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03): : 567 - 575
  • [4] Zidovudine prophylaxis and perinatal HIV-1 transmission
    Zuccotti, GV
    Ferraris, G
    Agostoni, C
    Rancilio, L
    Ravizza, M
    Bucceri, AM
    Riva, E
    Marini, A
    [J]. ACTA PAEDIATRICA, 1999, 88 (11) : 1298 - 1298
  • [5] The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076)
    McSherry, GD
    Shapiro, DE
    Coombs, RW
    McGrath, N
    Frenkel, LM
    Britto, P
    Culnane, M
    Sperling, RS
    [J]. JOURNAL OF PEDIATRICS, 1999, 134 (06): : 717 - 724
  • [6] Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load
    Golden, B
    Cooper, E
    Cundall, D
    Moy, R
    [J]. LANCET, 1999, 354 (9173): : 158 - 159
  • [7] Estimate of the HIV-1 prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in reducing perinatal transmission
    Amador, JTR
    Contreras, JR
    Bastero, R
    Barrio, C
    Moreno, P
    Delgado, R
    Muñoz, E
    Jiménez, J
    [J]. MEDICINA CLINICA, 2000, 114 (08): : 286 - 291
  • [8] Zidovudine resistance phenotype and risk of perinatal HIV-1 transmission in zidovudine monotherapy-treated mothers with moderately advanced disease
    Bauer, GR
    Welles, SL
    Colgrove, RR
    Pitt, J
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (03) : 312 - 319
  • [9] Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load - Reply
    Shaffer, N
    Siriwasin, W
    Bhadrakom, C
    Chotplayasunondh, T
    Chearskul, S
    [J]. LANCET, 1999, 354 (9173): : 157 - 158
  • [10] Prevention of perinatal transmission of human immunodeficiency virus: A progress report 2 years after completion of AIDS Clinical Trials Group trial 076
    Wilfert, CM
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) : 438 - 441
12345